Delivery Order SPE2DE21D0017-SPE2D626F6021
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $2,400.00 delivery order by the Defense Logistics Agency Medical Supply Chain on October 23, 2025, for COVID-19 virus test kits (KIT ID NOW COVID-19 VIR TST 24 TST). The contract utilizes fixed-price pricing with economic price adjustment provisions and is scheduled for completion by October 31, 2025. Performance will be conducted at the company's location in Lockhart, Florida. This delivery order was...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $2,400 delivery order (Contract No. 4569814561) for COVID-19 test kits on October 24, 2025, with an ultimate completion date of November 4, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and is performed in Lockhart, Florida. This delivery order is funded by the Defense Logistics Agency's Medical Supply Chain, which is a defense-oriented federal agency...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on April 28, 2025, for COVID-19 test kits with a ceiling value of $2,400.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of May 7, 2025, and will be performed in Lockhart, Florida. The contract was awarded without a set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain, operating under...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $4,800.00 on August 20, 2025, for COVID-19 test kits under contract 4569160719. This fixed-price contract with economic price adjustment has an ultimate completion date of August 29, 2025, and will be performed in Lockhart, Florida. The award was issued by the Defense Logistics Agency Medical Supply Chain without a set-aside designation, indicating open competition among...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $4,800.00 fixed-price delivery order with economic price adjustment on June 2, 2025, for COVID-19 virus test kits (KIT ID NOW COVID-19 VIR TST 24 TST). The contract, which carries no set-aside designation indicating open competition, is scheduled for ultimate completion on June 10, 2025, and will be performed in Lockhart, Florida. Funding is provided by the Defense Logistics Agency's Medical Supply...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on September 18, 2025, for COVID-19 test kits to support the Defense Logistics Agency Medical Supply Chain. The contract, designated as a fixed-price agreement with economic price adjustment provisions, carries an ultimate completion date of September 29, 2025, and will be performed in Lockhart, Florida. No set-aside designation was applied to this award, indicating the...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order contract valued at $6,000 for COVID-19 test kits by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on September 16, 2025, with an ultimate completion date of September 25, 2025, utilizes a fixed-price structure with economic price adjustment provisions and was awarded without a set-aside designation, indicating full and open competition. Performance of this...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $3,600.00 on September 9, 2025, for COVID-19 test kits under contract 4569386625. The contract utilizes fixed-price pricing with economic price adjustment and has an ultimate completion date of September 18, 2025. Performance will occur in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. The funding source is the Defense...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on July 14, 2025, for COVID-19 test kits under contract number 4568782066. The contract is a fixed-price delivery order with economic price adjustment provisions and will be performed in Lockhart, Florida, with an ultimate completion date of July 23, 2025. The award was made without set-aside designation, indicating open competition. Funding is provided through the...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment for COVID-19 test kits on August 7, 2025, with an ultimate completion date of August 18, 2025. The contract, issued without set-aside designation, is funded by the Defense Logistics Agency Medical Supply Chain and specifies performance at the contractor's facility in Lockhart, Florida. This delivery order represents a continuation of...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D626F6021Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $3,600 fixed-price delivery order with economic price adjustment on October 28, 2025, for COVID-19 virus test kits (Kit ID NOW COVID-19 VIR TST 24 TST). The contract is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by November 6, 2025, with performance based in Lockhart, Florida. This delivery order was awarded on a full and open basis without set-aside designation and represents a task order issued under an existing indefinite delivery vehicle with the Defense Logistics Agency. Abbott Rapid DX has established itself as a critical federal supplier of point-of-care diagnostic testing equipment and supplies, particularly for COVID-19 antigen and rapid molecular tests. The company maintains an extensive portfolio of active contracts across multiple federal healthcare agencies, including the Department of Veterans Affairs Integrated Service Networks, Defense Health Agency, and Indian Health Service. The modest ceiling value of this specific delivery order reflects the routine, consumable nature of rapid test kit procurement within the Medical Supply Chain's broader operations to support federal healthcare readiness and pandemic preparedness capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 10/28/25 |